Literature DB >> 16385472

Hsp90 inhibitors: small molecules that transform the Hsp90 protein folding machinery into a catalyst for protein degradation.

Brian S J Blagg1, Timothy D Kerr.   

Abstract

The 90 kDa heat shock proteins (Hsp90) are responsible for the conformational maturation of nascent polypeptides and the renaturation of denatured proteins. In transformed cells, numerous mutated and overexpressed proteins rely on the Hsp90 protein folding machinery for tumor progression. The Hsp90-mediated protein folding process is dependent upon ATP, and when inhibitors of ATP are present, the Hsp90 machinery is unable to fold client proteins into their biologically active form, which results in the degradation of protein substrates via the ubiquitin-proteasome pathway. Consequently, Hsp90 has evolved into a promising anti-cancer target because multiple oncogenic proteins can be simultaneously degraded as a consequence of Hsp90 inhibition. This review serves to explain the Hsp90 protein folding process, the impact of Hsp90 inhibition, the identification of natural product inhibitors, and the development of rationally designed inhibitors of the Hsp90 protein folding machinery. Copyright 2005 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16385472     DOI: 10.1002/med.20052

Source DB:  PubMed          Journal:  Med Res Rev        ISSN: 0198-6325            Impact factor:   12.944


  73 in total

1.  Development of a Grp94 inhibitor.

Authors:  Adam S Duerfeldt; Laura B Peterson; Jason C Maynard; Chun Leung Ng; Davide Eletto; Olga Ostrovsky; Heather E Shinogle; David S Moore; Yair Argon; Christopher V Nicchitta; Brian S J Blagg
Journal:  J Am Chem Soc       Date:  2012-05-29       Impact factor: 15.419

2.  Cytotoxic small molecule dimers and their inhibitory activity against human breast cancer cells.

Authors:  M Kyle Hadden; Brian S J Blagg
Journal:  Bioorg Med Chem Lett       Date:  2007-07-13       Impact factor: 2.823

Review 3.  Regulators of endothelial and epithelial barrier integrity and function in acute lung injury.

Authors:  Rudolf Lucas; Alexander D Verin; Stephen M Black; John D Catravas
Journal:  Biochem Pharmacol       Date:  2009-02-03       Impact factor: 5.858

Review 4.  Anticancer Inhibitors of Hsp90 Function: Beyond the Usual Suspects.

Authors:  Gaurav Garg; Anuj Khandelwal; Brian S J Blagg
Journal:  Adv Cancer Res       Date:  2016-02-10       Impact factor: 6.242

5.  A Transcriptionally Definable Subgroup of Triple-Negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 Inhibition.

Authors:  Kevin Shee; Jason D Wells; Matthew Ung; Riley A Hampsch; Nicole A Traphagen; Wei Yang; Stephanie C Liu; Megan A Zeldenrust; Liewei Wang; Krishna R Kalari; Jia Yu; Judy C Boughey; Eugene Demidenko; Arminja N Kettenbach; Chao Cheng; Matthew P Goetz; Todd W Miller
Journal:  Clin Cancer Res       Date:  2019-09-26       Impact factor: 12.531

Review 6.  New developments in Hsp90 inhibitors as anti-cancer therapeutics: mechanisms, clinical perspective and more potential.

Authors:  Yanyan Li; Tao Zhang; Steven J Schwartz; Duxin Sun
Journal:  Drug Resist Updat       Date:  2009 Feb-Apr       Impact factor: 18.500

7.  Gedunin, a novel hsp90 inhibitor: semisynthesis of derivatives and preliminary structure-activity relationships.

Authors:  Gary E L Brandt; Matthew D Schmidt; Thomas E Prisinzano; Brian S J Blagg
Journal:  J Med Chem       Date:  2008-09-25       Impact factor: 7.446

Review 8.  Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocket.

Authors:  Alison Donnelly; Brian S J Blagg
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

9.  A novel HSP90 modulator with selective activity against thyroid cancers in vitro.

Authors:  Abbas Samadi; Peter Loo; Rithwi Mukerji; Gemma O'Donnell; Xiaqin Tong; Barbara N Timmermann; Mark S Cohen
Journal:  Surgery       Date:  2009-12       Impact factor: 3.982

10.  Hsp90 charged-linker truncation reverses the functional consequences of weakened hydrophobic contacts in the N domain.

Authors:  Shinji Tsutsumi; Mehdi Mollapour; Christian Graf; Chung-Tien Lee; Bradley T Scroggins; Wanping Xu; Lenka Haslerova; Martin Hessling; Anna A Konstantinova; Jane B Trepel; Barry Panaretou; Johannes Buchner; Matthias P Mayer; Chrisostomos Prodromou; Len Neckers
Journal:  Nat Struct Mol Biol       Date:  2009-10-18       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.